Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Cutaneous Melanoma (Stage IV)”

733 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 733 results

Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Not applicableNo Longer AvailableNCT04489433
What this trial is testing

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00006385
What this trial is testing

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749
What this trial is testing

A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 71
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00509288
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02073123
What this trial is testing

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III MelanomaStage IV Melanoma
NewLink Genetics Corporation 132
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT01134614
What this trial is testing

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Advanced MelanomaMetastatic MelanomaRecurrent Melanoma+6 more
National Cancer Institute (NCI) 245
Testing effectiveness (Phase 2)WithdrawnNCT01833767
What this trial is testing

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Western Regional Medical Center
Early research (Phase 1)Study completedNCT00349206
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Study completedNCT01196416
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Early research (Phase 1)Study completedNCT01703507
What this trial is testing

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Cancer Center at Thomas Jefferson University 17
Testing effectiveness (Phase 2)Temporarily pausedNCT00042497
What this trial is testing

Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma

Who this might be right for
Melanoma
Anosys 60
Early research (Phase 1)UnknownNCT00006035
What this trial is testing

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00658892
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Load More Results